Global Market Study on Intravitreal (IVT) Injectables: Chronic Retinal Conditions to Uplift Sales of Anti-VEGF IVT Injectables


  • Rep Id : XPLREP3668
  • Published On : February, 2019
  • No. of Pages : 276
  • Category : Healthcare
  • Publisher : Persistence Market Research

XploreMR recently published report titled ‘Intravitreal (IVT) Injectables Market: Global Industry Analysis 2013 – 2017 and Forecast 2018–2028' offers a comprehensive assessment of the key dynamics pertaining to the intravitreal (IVT) injectables market. The report presents growth prospects for the intravitreal injectables (IVT) market, which have been obtained with maximum precision through detailed research on the historic as well as current growth parameters.

The report discusses the prominent factors that are likely to have a significant impact on the development of the intravitreal (IVT) injectables market during the forecast period. This information will prove to be key for market players to modify their manufacturing and marketing strategies and envisage maximum growth in the intravitreal (IVT) injectables market in the coming years.

Chapter 1 – Executive Summary

The report commences with an executive summary, which comprises a summary of the key findings and statistics pertaining to the intravitreal (IVT) injectables market. This section also provides market value (US$ Million) estimates for the leading segments of the intravitreal (IVT) injectables market.

Chapter 2 – Market Overview

Readers can find a detailed taxonomy and definitions in this chapter to help them better understand the basic information about the intravitreal (IVT) injectables market dynamics, pricing analysis, list of key manufacturers and key regulation policies included in the succeeding sections of the report.

Chapter 3 – Global Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028 2018 – 2028 by Drug Class

On the basis of drug class, the intravitreal (IVT) injectables market has been segmented into anti-VEGF, corticosteroids, antibiotics, antivirals and antifungals. In this chapter, readers can find information about the key trends and developments observed in the intravitreal (IVT) injectables market. The section also comprises market attractiveness analysis of the segments on the basis of drug class.

Chapter 4 – Global Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028 2018 – 2028 by Indication

Based on indication, the intravitreal (IVT) injectables market has been segmented into diabetic retinopathy, macular degeneration, endophthalmitis, retinal vein occlusions and others. In this section, readers can find information about device usage, key trends and technological developments in the intravitreal injectables (IVT) market along with market attractiveness analysis of the key segments based on indication.

Chapter 5 – Global Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028 2018 – 2028 by Distributional Channel

By distributional channel, the intravitreal (IVT) injectables market has been segmented into hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies and others. In this chapter, readers can find information about the key trends and developments identified in the intravitreal (IVT) injectables market and market attractiveness analysis of the key segments based on distributional channel.

Chapter 6 – Global Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028 2018 – 2028 by Region

This chapter explains how the intravitreal (IVT) injectables market is expected to grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

Chapter 7 – North America Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028

This chapter includes a detailed analysis of the growth of the intravitreal injectables (IVT) market, along with a country-wise assessment for various countries in North America, including the U.S. and Canada. Readers can also find information on regional trends, macro-economic factors and market growth on the basis of drug class, indication, distributional channel and country for the intravitreal injectables (IVT) market in North America.

Chapter 8 – Latin America Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028

Readers can find detailed information about pricing analysis and regional trends impacting the growth of the Latin American Intravitreal (IVT) Injectables market. This chapter also discusses growth prospects for the intravitreal (IVT) injectables market in leading LATAM countries, such as Brazil, Mexico and the Rest of the Latin America.

Chapter 9 – Europe Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028

Readers can find detailed information about the important growth parameters in the intravitreal injectables (IVT) market in several European countries, such as Germany, the U.K., France, Italy, Spain, BENELUX, Russia and the rest of Europe.

Chapter 10 – South Asia Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028

Readers can find detailed information about the important growth parameters in the intravitreal injectables (IVT) market for several South Asian countries, such as the India, Thailand, Indonesia, Malaysia, and Rest of South Asia.

Chapter 11 – East Asia Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028

Readers can find thorough information about the various parameters expected to impact the East Asia intravitreal injectables (IVT) market during the forecast period 2018 – 2028. China, Japan, South Korea are the leading countries/regions in East Asia and hence, the prime subject of assessment in this chapter.

Chapter 12 – Oceania Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028

Readers can find information on the important factors expected to make a significant impact on the growth of the intravitreal (IVT) injectables market in Oceania countries including Australia and New Zealand during the forecast period 2018 – 2028.

Chapter 13 – MEA Intravitreal (IVT) Injectables Market Analysis 2013 – 2017 and Forecast 2018-2028 2018 – 2028

Readers can find detailed information on how the intravitreal (IVT) injectables market is expected to grow in major countries/regions of the MEA region, such as GCC Countries, Turkey, Northern Africa, South Africa, and the Rest of MEA during the period 2018 – 2028.

Chapter 14 – Competition Landscape, Company Share, and Company Profiles

In this chapter, readers can find a comprehensive list of all leading stakeholders in the intravitreal (IVT) injectables market and detailed information about each company, including company overview, offered products, SWOT analysis, key strategy and recent company developments. The market players featured in the report include F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Novartis AG, Allergan, Alimera Sciences, ThromboGenics, Inc., and Bristol-Myers Squibb Company.

Chapter 15 – Assumptions and Acronyms

This chapter of the intravitreal (IVT) injectables market report includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 16 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information about the intravitreal (IVT) injectables market.

Intravitreal Ivt Injectables Market